Auris Medical Receives FDA Fast Track Designation for AM-111 in Acute Sensorineural Hearing Loss
Feb 24, 2017 13:01 pm UTC| Business
Zug, Switzerland, Feb. 24, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that...
BASF: Sales and earnings in the 4th quarter considerably above prior-year quarter
Feb 24, 2017 13:01 pm UTC| Business
4th quarter 2016: Sales €14.8billion (plus 7% compared with prior-year quarter)EBIT before special items €1.2billion (plus 15% compared with prior-year quarter) Full year 2016: Sales €57.6billion (minus 18% compared...
BASF: Sales and earnings in the 4th quarter considerably above prior-year quarter
Feb 24, 2017 13:01 pm UTC| Business
4th quarter 2016: Sales €14.8billion (plus 7% compared with prior-year quarter)EBIT before special items €1.2billion (plus 15% compared with prior-year quarter) Full year 2016: Sales €57.6billion (minus 18% compared...
ChinaCache to Participate in Upcoming Industry-leading Conferences
Feb 24, 2017 13:01 pm UTC| Business
BEIJING, Feb. 24, 2017 -- ChinaCache International Holdings Ltd. ("ChinaCache" or the "Company") (NASDAQ:CCIH), the leading total solutions provider of Internet content and application delivery services in China, today...
ChinaCache to Participate in Upcoming Industry-leading Conferences
Feb 24, 2017 13:01 pm UTC| Business
BEIJING, Feb. 24, 2017 -- ChinaCache International Holdings Ltd. ("ChinaCache" or the "Company") (NASDAQ:CCIH), the leading total solutions provider of Internet content and application delivery services in China, today...
Bioblast Pharma Reports Fourth Quarter and Year End 2016 Financial Results
Feb 24, 2017 13:00 pm UTC| Business
TEL AVIV, Israel, Feb. 24, 2017 -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the fourth quarter ended December 31, 2016 and...
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR
Feb 24, 2017 13:00 pm UTC| Business
TORONTO, Feb. 24, 2017 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...